Electroceuticals/Bioelectric Medicine Market Will Witness Growth Based On Increasing Investment In The Development Of Advanced Bioelectric Medicine Till 2025:Grand View Research,inc.
The global electroceuticals/bioelectric medicine market is
expected to reach USD 35.5 billion by 2025, according to a new report by Grand
View Research, Inc. Rising geriatric population is the major factor that is
expected to propel growth during the forecast period. Aging population is prone
to various diseases such as cardiac arrhythmias, Parkinson's disease,
Alzheimer's disease, epilepsy, and depression. There are various advanced
electroceuticals including implantable cardioverter defibrillators, cochlear
implants, cardiac pacemakers, and spinal cord stimulators, which can be used
for the treatment of these conditions.
Increasing investment in the
development of advanced bioelectric medicine is another major factor supporting
the growth of the electroceuticals market. For instance, in FY 2016, Medtronic,
a leading bioelectric medicine manufacturer, invested around USD 2,224 million
in R&D for development of advanced products. Technological advancements in
these products propel their adoption in treatment of chronic diseases such as
cardiac arrhythmias and Parkinson's disease. The technological advanced
electroceuticals provide high reliability and efficiency during treatment.
Browse full research report on Electroceuticals/Bioelectric
Medicine Market: http://www.grandviewresearch.com/industry-analysis/electroceuticals-bioelectric-medicine-market
Further Key Findings From
The Report Suggest:
- Implantable cardioverter defibrillators segment was
the largest revenue-generating segment of the electroceuticals market in
2016 owing to large application of these products for the treatment of
arrhythmia
- The implantable electroceuticals devices segment
accounted for the largest revenue share in the bioelectric medicine market
in 2016 owing to technological advancements
- In the application segment, the arrhythmia segment
accounted for the largest share in 2016 and is expected to maintain its
dominance throughout forecast period
- The hospitals dominated the electroceuticals market
in terms of revenue in 2016 due to the escalating number of
electroceutical devices implant procedures in hospitals
- The North America bioelectric medicine market is the
leading regional sector and accounted for the largest revenue share in
2016 mainly due to the existence of large number of medical devices
companies in this region
- The Asia Pacific region is expected to grow at a
highest growth rate during the study period. The developing healthcare
infrastructure and rising healthcare awareness in the Asian countries such
as China and India is a major factor contributing to the growth in this
region
- Some of the major players include Medtronic; St. Jude
Medical; Boston Scientific Corporation; Cochlear Ltd.; Sonova; LivaNova
PLC; Biotronik; Nevro Corp.; SECOND SIGHT; and electroCore LLC.
Browse more reports of this category by Grand View
Research: http://www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the global
electroceuticals market on the basis of product, type, application, end-use,
and region:
Product Outlook (Revenue, USD Million; 2014 - 2025)
- Implantable
cardioverter defibrillators
- Cardiac
pacemakers
- Cochlear
implants
- Spinal
cord stimulators
- Deep
brain stimulators
- Transcutaneous
electrical nerve stimulators
- Sacral
nerve stimulators
- Vagus
nerve stimulators
- Other
bioelectric medicines
Type Outlook (Revenue, USD Million; 2014 - 2025)
- Implantable
electroceutical devices
- Noninvasive
electroceutical devices
Application Outlook (Revenue, USD Million; 2014 - 2025)
- Arrhythmia
- Pain
management
- Sensorineural
hearing loss
- Parkinson’s
disease
- Tremor
- Depression
- Treatment-resistant
depression
- Epilepsy
- Urinary
and fecal incontinence
- Others
End-Use Outlook (Revenue, USD Million; 2014 - 2025)
- Hospitals
- Others
Regional Outlook (Revenue, USD Million; 2014 - 2025)
- North
America
- U.S.
- Canada
- Europe
- Germany
- UK
- Asia
Pacific
- Japan
- China
- India
- Latin
America
- Brazil
- Mexico
- MEA
- South
Africa
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides
syndicated research reports, customized research reports, and consulting
services. To help clients make informed business decisions, we offer market
intelligence studies ensuring relevant and fact-based research across a range
of industries, from technology to chemicals, materials and healthcare.
Comments
Post a Comment